The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
MMs collecting for the next step up as I said previously they live balanced trades from now to 7/8p
This particular share has a lot of onlookers, and I am not surprised, this has great potential for LTH and this CEO who actually does something at the company to earn her wages has great potential and respect in the market.
I see this share value as a minimum of 7P and with better news on TU this will have the potential to rerate as confidence grow with the BOD. But at the moment it's a screaming buy.
Who sells 100,000 shares on a bull run?
Got to be MMs feeding the PIs. lol
A little bit of overhang gone, and this looks to be trading real-time with no lose shares knocking about, as for Predictions should comfortably hit 7p but hoping on a good TU and 10p a real possibility of building on a foundation for further movement north from 8-10p December
After spending hours trolling through the media, this company has been leaning into profit since January, so if the spending hasn't been too excessive, this could be a surprise TU?: a year early with profit. 2022 looks very bright for the LTH, and this lady has a way of turning lead into gold and building on success, but I would settle for silver at this point.
This is a repeat of what occurred last time in July. The share was heavily bought like now, not just small punts but large chunks.
Then it wouldn't move, from 1.6 and then all of a sudden jump to 6.4 once the TU was issued, but that wasn't on particular great figures; this time, it's going to be better they have said the trading is better.
So IMHO minimum going to be 6p, but depending on figures could peak at 12p.
Well, it would be if you can buy some? going to NT for more than4k
Over 2 weeks away from TU and moving up with some quite large trades, have we got a bit of a leak in this boat?
It would seem with a decent update; this could fly. This CEO has sites on building a brand from the work she s putting in, seems a good LTH as they get the redirection running straight and ahead of time.
It’s certainly looking like they have faith in this treatment otherwise why waste their time with these tests. We already know it reduces lung damage In people with moderate COVID-19.
With the opening bid and share price this morning the MM is definitely trying to keep this down while they load up shares to sell your back? time will tell with the late buys after close today.
I guess the real bomb will hit at the AGM that will send this share price north. It seems the market is punishing the board of directors for the late promises
This is the best news I’ve seen RNS From Tils In the last 12 months.
Even the M&Ms have been caught offguard here trying to collect shares for what’s going to be a major trip north. It seems there’s going to be plenty of news at the AGM.with these two trials surely going into phase 3 trials In record time using the shortest route and cheapest. to see whether or not this has the answer to the COVID-19 pandemic ? this has the potential to be massive looking forward to the trip north.
UK COVID-19 Therapeutics Advisory Panel (UK-CTAP) What it means for Tiziana Life Sc , If the treatment works this could be on the market and approved before Christmas and the way these buys are coming in the word is out.
next week big moves north IMHO and about time.
An independent COVID-19 Therapeutics Advisory Panel (UK-CTAP), chaired by Professor Patrick Chinnery, will advise on what treatments should be proposed for testing through RECOVERY+, REMAP-CAP, PRINCIPLE and AGILE. The panel is formed by a group of experts with no vested interests from relevant backgrounds who have broad expertise covering key issues.
The panel will take specialist advice from sub-panels with expertise in strategically important areas for the treatment of COVID-19. These areas will change as we learn more about disease mechanisms in COVID-19 and its complications, and we advance our knowledge of the most effective treatments.
The final decision on which treatments will be included in these trials will lie with the Chief Investigators, who have ultimate responsibility for the delivery of the trials and Professor Chris Whitty, the Chief Medical Officer for England and Chief Scientific Adviser for the Department of Health and Social Care.
The UK-CTAP will be supported by a UK Research and Innovation (UKRI) led secretariat. The membership of the group and the record of the meetings will be published and updated periodically to reflect any changes in the membership details and the drug prioritisation process.
It looks like my 3 Dollar prediction coming together. this looks to finish today above 87P and one more little promotion tomorrow £1 incoming before the start of the AGM next week
charts at Nasdaq looks set to hit $3 tomorrow is it wishful thinking?
Nasdaq Looks all set to move north today, and with the AGM set for next Friday, let's hope they have news to heat this one a bit.
Pre-Market Time (ET)
07:00:00 $2.6 1
AGM 25-Jun-2021
Looks like 73p is bottom and has been tested a few time so safe at this point and investors know it big boys coming back now this will be 10% up on the day.
Lekoil Nigeria Limited has said despite the decision of (“Lekoil Cayman”) to terminate the service of Mr. Lekan Akinyanmi and remove him as Lekoil Cayman CEO as announced 3 June 2021, Akinyanmi remains on the Board of Lekoil Nigeria Limited and also its Chief Executive Officer.
The company in statement made available to Daily Sun said Akinyanmi created and executed the vision of an independent indigenous Nigerian energy company that is Lekoil, for this generation and in this emerging market and he has always worked with the best interest of Lekoil shareholders in mind). And there you have it, Looks like a crowbar is needed to remove this parasite and a great deal of time.
I can't see any evidence now that this is listed or was ever planned to be listed on the London or Nasdaq apart from nondescript remarks and suggestion via the BOD.
They previously RNS that $57.25 Million Offering would be completed and that Accustem will be launch on the LSE before the end of year2020; clearly a tall tail as no such request or IPO was even started that I can see, then came the notification Accustem would be launched on Nasdaq only, again I will be taking this with a pinch of salt as it seems they don't even meet the standards set to list there, and a not holding my breath.
So it seems we were sold a box of tricks to support the inflated $57.25 Million Offering that would never have been filled if not for the 1-1 share offer. That's the way I see it, and with no news coming down from above and the evidence in hand, why would I see it any other way.
Over the next few weeks, this will see the 70p barrier tested again, but this time I don't think the MMs will be able to rinse and repeat until it hits 58p/62p
The market makers what are they saying?
280 k approx more buys than sells Monday to Wednesday and up from 72p to 86p that's 20%
Today 210k more sells than buys down 4%? seems there up to their tricks certainly was not to try and kick start this share back to life. Until Aqustem is sorted it's not going to happen. A lot of investors put their money here to get their bonus shares to be placed on the market in December, now that's not happened and still in the dark when it will happen.
Anybody here who can honestly say TILS even had intentions to do so, because there is absolutely no evidence to say that's what was intended. Who would want to invest in this BOD when they have little or no regard for their shareholders.
looks like things beginning to unclog in the NNPC Dam. potentially very good news on the horizon for shorecan
https://www.newsnow.co.uk/h/?search=nnpc